Skip to main content
logo
Genscript Biotech Corporation (GNNSF)
OTCMKTS · Delayed Price · Currency is USD
2.190
-0.010 (-0.45%)
Sep 4, 2025, 8:00 PM EDT

Genscript Biotech Revenue

Genscript Biotech had revenue of $518.77M in the half year ending June 30, 2025, with 32.57% growth. This brings the company's revenue in the last twelve months to $828.10M, down -10.43% year-over-year. In the year 2024, Genscript Biotech had annual revenue of $594.49M with 6.07% growth.

Revenue (ttm)
828.10M
Revenue Growth
-10.43%
P/S Ratio
6.12
Revenue / Employee
143.54K
Employees
5,568
Market Cap
5.07B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024594.49M34.01M6.07%
Dec 31, 2023560.48M-65.22M-10.42%
Dec 31, 2022625.70M135.60M27.67%
Dec 31, 2021490.10M99.25M25.39%
Dec 31, 2020390.85M117.49M42.98%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Veradigm588.02M
Elite Pharmaceuticals105.45M
Tian'an Technology Group2.12M
Glass House Brands221.55M
HealthLynked2.58M
Northwest Biotherapeutics1.09M
American Oncology Network1.76B
Silence Therapeutics27.17M
Revenue Rankings

Genscript Biotech News

More News